Glucocorticoid Pathway (HPA Axis), Pharmacodynamics
Pathways in the Glucocorticoid Pathway (HPA Axis), Pharmacodynamics SuperPath
| # | Name | Source | Genes |
|---|---|---|---|
| 1 | Glucocorticoid Pathway (HPA Axis), Pharmacodynamics | PharmGKB |
Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways
| # | Symbol | Description | Category | # Related Pathways |
|---|---|---|---|---|
| 1 | UCN | Urocortin | Protein Coding | 1 |
| 2 | POMC | Proopiomelanocortin | Protein Coding | 1 |
| 3 | CRH | Corticotropin Releasing Hormone | Protein Coding | 1 |
| 4 | CRHR1 | Corticotropin Releasing Hormone Receptor 1 | Protein Coding | 1 |
| 5 | CRHR2 | Corticotropin Releasing Hormone Receptor 2 | Protein Coding | 1 |
| 6 | UCN3 | Urocortin 3 | Protein Coding | 1 |
| 7 | UCN2 | Urocortin 2 | Protein Coding | 1 |
Disorders associated with Glucocorticoid Pathway (HPA Axis), Pharmacodynamics SuperPath
according to GeneCards Suite gene sharing
| # | Disorder | Type | Genes | Score |
|---|---|---|---|---|
| 1 | Obesity, early-onset, with adrenal insufficiency and red hair | Enrichment | POMC | 2.81 |
| 2 | Mpv17-related mitochondrial dna maintenance defect | Enrichment | UCN | 2.81 |
| 3 | Obesity due to pro-opiomelanocortin deficiency | Enrichment | POMC | 2.81 |
| 4 | Mitochondrial dna depletion syndrome 6 | Enrichment | UCN | 2.69 |
| 5 | Charcot-marie-tooth disease, axonal, type 2ee | Enrichment | UCN | 2.69 |
| 6 | Autosomal dominant sleep-related hypermotor epilepsy | Enrichment | CRH | 2.44 |
| 7 | Body mass index quantitative trait locus 11 | Enrichment | POMC | 1.59 |